You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Patent Applications for glycopyrronium tosylate


✉ Email this page to a colleague

« Back to Dashboard


US Patent Applications for glycopyrronium tosylate

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
⤷  Subscribe 9,006,462 GLYCOPYRROLATE SALTS 2014-08-29 Patented Case 2015-03-25
⤷  Subscribe ⤷  Subscribe GLYCOPYRROLATE SALTS 2015-03-10 Notice of Allowance Mailed -- Application Received in Office of Publications 2015-11-11
⤷  Subscribe ⤷  Subscribe PROCESS FOR PRODUCTION OF GLYCOPYRRONIUM TOSYLATE 2015-08-19 Patented Case 2018-03-07
⤷  Subscribe ⤷  Subscribe Glycopyrrolate Salts 2016-01-07 Patented Case 2017-03-15
⤷  Subscribe ⤷  Subscribe GLYCOPYRROLATE SALTS 2017-02-21 Non Final Action Mailed 2017-08-04
>US Patent Application >Patent No. >Title >Patent Filing Date >Patent Application Status >Status Updated

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.